Search Results

Displaying Results 1-1 of 1 "'CRNX'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines

Dec 19, 2025, 07:55 ET Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines

(NASDAQ: GTBP), ADC Therapeutics SA (NYSE: ADCT), Sutro Biopharma, Inc. (NASDAQ: STRO), Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX), and TScan Therapeutics, Inc. (NADSAQ: TCRX).

More news about: Equity Insider

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.